You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Longitudinal drug data for patients who stayed over 3 days in hospital and in hospice

From: A comparison of drugs and procedures of care in the Italian hospice and hospital settings: the final three days of life for cancer patients

  Hospital N = 106 Hospice N = 107 P-value
Potentially inappropriate drugs n. % n. %  
Supplements      
Drug not given 59 55.7 97 90.7  
Drug given continuously 14 13.2 1 0.9  
Drug stopped in final three days 30 28.3 8 7.5  
Drug started in final three days 1 0.9 1 0.9  
Other 2 1.9 - - .000
Replacement hormones      
Drug not given 87 82.1 94 87.9  
Drug given continuously 12 11.3 1 0.9  
Drug stopped in final three days 7 6.6 10 9.3  
Drug started in final three days - - - -  
Other - - 2 1.9 .007
Antiulcer Drugs      
Drug not given 25 23.6 37 34.6  
Drug given continuously 27 25.5 23 21.5  
Drug stopped in final three days 50 47.2 41 38.3  
Drug started in final three days 1 0.9 2 1.9  
Other 3 2.8 4 3.7 .405
Anticoagulents      
Drug not given 45 42.5 73 68.2  
Drug given continuously 14 13.2 6 5.6  
Drug stopped in final three days 40 37.7 21 19.6  
Drug started in final three days 3 2.8 - -  
Other 4 3.8 7 6.5 .001
Antihypertensives      
Drug not given 71 67.0 97 90.7  
Drug given continuously 10 9.4 - -  
Drug stopped in final three days 19 17.9 9 8.4  
Drug started in final three days 2 1.9 1 0.9  
Other 4 3.8 - - .000
Antiarryhthmics      
Drug not given 86 81.1 97 90.7  
Drug given continuously 8 7.5 3 2.8  
Drug stopped in final three days 10 9.4 6 5.6  
Drug started in final three days 1 0.9 1 0.9  
Other 1 0.9 - - .295
Antibiotics      
Drug not given 41 38.7 90 84.1  
Drug given continuously 25 23.6 5 4.7  
Drug stopped in final three days 36 24.5 9 8.4  
Drug started in final three days 1 0.9 3 2.8  
Other 3 2.8 - - .000
Steroids      
Drug not given 44 41.5 39 36.4  
Drug given continuously 25 23.6 22 20.6  
Drug stopped in final three days 26 24.5 35 32.7  
Drug started in final three days 8 7.5 3 2.8  
Other 3 2.8 8 7.5 .174
Vasodilator Drugs      
Drug not given 93 87.7 102 95.3  
Drug given continuously 5 4.7 2 1.9  
Drug stopped in final three days 5 4.7 3 2.8  
Drug started in final three days - - - -  
Other 3 2.8 - - .158
Dopamine      
Drug not given 100 94.3 107 100  
Drug given continuously - - - -  
Drug stopped in final three days 1 0.9 - -  
Drug started in final three days 4 3.8 - -  
Other 1 0.9 - - .101
Potentially appropriate drugs      
Opioids      
Drug not given 31 29.2 9 8.4  
Drug given continuously 30 28.3 70 65.4  
Drug stopped in final three days 25 23.6 17 15.9  
Drug started in final three days 14 13.2 8 7.5  
Other 6 5.7 3 2.8 .001
Midazolam      
Drug not given 100 94.3 30 28.0  
Drug given continuously 2 1.9 39 36.4  
Drug stopped in final three days - - 14 13.1  
Drug started in final three days 4 3.8 19 17.8  
Other - - 5 4.7 .000
Haloperidol      
Drug not given 94 88.7 38 35.5  
Drug given continuously 6 5.7 46 43.0  
Drug stopped in final three days 2 1.9 12 11.2  
Drug started in final three days 2 1.9 8 7.5  
Other 2 1.9 3 2.8 .000
Drugs for pulmonary secretions      
Drug not given 102 96.2 54 50.5  
Drug given continuously -0 - 27 25.2  
Drug stopped in final three days 2 1.9 5 4.7  
Drug started in final three days 2 1.9 15 14.0  
Other - - 6 5.6 .000
Drugs for Nausea/Vomiting      
Drug not given 90 84.9 81 75.7  
Drug given continuously 4 3.8 5 4.7  
Drug stopped in final three days 8 7.5 17 15.9  
Drug started in final three days 4 3.8 2 1.9  
Other - - 2 1.9 .166